Skip to Main Content

Author Details

Fernando Lecanda
University of Navarra, Center for Applied Medical Research
1995
87
38
PMIDPaper TitleJournal TitlePublished Year
36058299The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in Melanoma.J Invest Dermatol2023
36058299The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in Melanoma.J Invest Dermatol2023
37596165Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma.Cancer Epidemiol2023
37816716Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer.Nat Commun2023
36719675ENPP1 Immunobiology as a Therapeutic Target.Clin Cancer Res2023
37210549The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer.Mol Cancer2023
37328838Correction: The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer.Mol Cancer2023
36607777LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth.Clin Cancer Res2023
36674468Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast Cancer.Int J Mol Sci2023
37596165Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma.Cancer Epidemiol2023
37816716Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer.Nat Commun2023
37210549The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer.Mol Cancer2023
37328838Correction: The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer.Mol Cancer2023
36719675ENPP1 Immunobiology as a Therapeutic Target.Clin Cancer Res2023
36607777LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth.Clin Cancer Res2023
36674468Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast Cancer.Int J Mol Sci2023
34971753Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis.Cancer Lett2022
36176621Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood.Bioeng Transl Med2022
34971753Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis.Cancer Lett2022
35191482Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer.Cancer Discov2022
36176621Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood.Bioeng Transl Med2022
35191482Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer.Cancer Discov2022
32941955Dose volume histogram constraints in patients with head and neck cancer treated with surgery and adjuvant HDR brachytherapy: A proposal of the head and neck and skin GEC ESTRO Working group.Radiother Oncol2021
33887357FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted.J Hepatol2021
32941955Dose volume histogram constraints in patients with head and neck cancer treated with surgery and adjuvant HDR brachytherapy: A proposal of the head and neck and skin GEC ESTRO Working group.Radiother Oncol2021
33887357FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted.J Hepatol2021
32191290Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.JAMA Oncol2020
32191290Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.JAMA Oncol2020
31874105The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas.J Clin Invest2020
33047515Sarcoma treatment in the era of molecular medicine.EMBO Mol Med2020
32686768Wnt signaling and Loxl2 promote aggressive osteosarcoma.Cell Res2020
32674353Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma.Cancers (Basel)2020
35121837Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade.Nat Cancer2020
35121837Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade.Nat Cancer2020
31874105The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas.J Clin Invest2020
33047515Sarcoma treatment in the era of molecular medicine.EMBO Mol Med2020
32686768Wnt signaling and Loxl2 promote aggressive osteosarcoma.Cell Res2020
32674353Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma.Cancers (Basel)2020
30642298CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process.BMC Cancer2019
30642298CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process.BMC Cancer2019
31166114YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.Am J Respir Crit Care Med2019
31015176Long-term results of Perioperative High Dose Rate Brachytherapy (PHDRB) and external beam radiation in adult patients with soft tissue sarcomas of the extremities and the superficial trunk: Final results of a prospective controlled study.Radiother Oncol2019
31001273Complement in Metastasis: A Comp in the Camp.Front Immunol2019
31015176Long-term results of Perioperative High Dose Rate Brachytherapy (PHDRB) and external beam radiation in adult patients with soft tissue sarcomas of the extremities and the superficial trunk: Final results of a prospective controlled study.Radiother Oncol2019
31166114YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.Am J Respir Crit Care Med2019
31001273Complement in Metastasis: A Comp in the Camp.Front Immunol2019
29327939Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.Am J Respir Crit Care Med2018
30415833Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial.Brachytherapy2018
30515265Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcoma.Oncotarget2018
29383033Radiation effects on antitumor immune responses: current perspectives and challenges.Ther Adv Med Oncol2018
  • 1 - 50 of 174

Recommended Authors

Cao Fang
University of California
Career Start Year 2011
Number of shared co-authors 0
Yang Chen
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Young K Song
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 12
Xiaoyong Huang
Medical College, Yan'an University
Career Start Year 2007
Number of shared co-authors 0
Tao Wei
Urumqi Friendship Hospital
Career Start Year 2005
Number of shared co-authors 0
Arnulfo Mendoza
National Cancer Institute, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 7
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
Russell Bainer
University of California berkeley
Career Start Year 2003
Number of shared co-authors 0
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 2
Sung Wook Seo
Samsung Medical Center, Sungkyunkwan University
Career Start Year 2001
Number of shared co-authors 0
Qingxia Wei
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 2000
Number of shared co-authors 2
Oscar M Tirado
Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)/CIBERONC
Career Start Year 2000
Number of shared co-authors 11
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 3
Alana L Welm
Huntsman Cancer Institute, University of Utah
Career Start Year 1999
Number of shared co-authors 1
Roya Navab
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1997
Number of shared co-authors 1
Chun-Liang Chen
National Dong Hwa University
Career Start Year 1997
Number of shared co-authors 1
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 2
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Robert L Satcher
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 1
Aykut Uren
Georgetown University Medical Center
Career Start Year 1991
Number of shared co-authors 15
Cun-Yu Wang
University of California, Los Angeles (university of california los angeles)
Career Start Year 1991
Number of shared co-authors 1
Roger Chammas
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 1
Dirk Geerts
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 7
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 0
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Francis J Hornicek
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year 1983
Number of shared co-authors 3
David M Jablons
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year 1981
Number of shared co-authors 1
Mary C Farach-Carson
The University of Texas Health Science Center at Houston School of Dentistry
Career Start Year 1981
Number of shared co-authors 0
Patricia S Steeg
Center for Cancer Research, National Cancer Institute
Career Start Year 1980
Number of shared co-authors 9

Collaborators

Ana Pati??o-Garc??a
Center for Applied Medical Research.
Co-authored papers 23
Luis Sierrases??maga
Clinica Universidad de Navarra
Co-authored papers 9
Javier De Las Rivas
Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL)
Co-authored papers 9
Lisa Mirabello
National Cancer Institute
Co-authored papers 8
Richard Gorlick
University of Texas MD Anderson Cancer Center
Co-authored papers 8
Sharon A Savage
Clinical Genetics Branch, National Cancer Institute (NCI)
Co-authored papers 8
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 8
Claudia Maria Hattinger
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 7
Adrienne M Flanagan
University College London, UCL Cancer Institute
Co-authored papers 7
Irene L Andrulis
University of Toronto
Co-authored papers 7
Jay S Wunder
University of Toronto
Co-authored papers 7
Meredith Yeager
Frederick National Laboratory for Cancer Research
Co-authored papers 7
Donald A Barkauskas
Keck School of Medicine of the University of Southern California
Co-authored papers 7
Rafael Mart??nez-Monge
Clinica Universitaria de Navarra
Co-authored papers 7
Julie M Gastier-Foster
Baylor College of Medicine
Co-authored papers 7
Massimo Serra
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 7
Logan G Spector
Division of Epidemiology and Clinical Research, University of Minnesota
Co-authored papers 6
Piero Picci
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 6
Nalan Gokgoz
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 6
David M Thomas
Garvan Institute of Medical Research
Co-authored papers 6
Margaret A Tucker
National Cancer Institute
Co-authored papers 6
Roberto Tirabosco
University College London, UCL Cancer Institute
Co-authored papers 6
Katia Scotlandi
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 5
Fernanda Amary
Royal National Orthopaedic Hospital
Co-authored papers 5
Robert N Hoover
National Cancer Institute
Co-authored papers 5
Silvia Regina Caminada de Toledo
Pediatric Oncology Institute (IOP/GRAACC), Federal University of Sao Paulo
Co-authored papers 4
Zhaoming Wang
St Jude Children's Research Hospital
Co-authored papers 4
Neyssa Marina
Stanford University School of Medicine
Co-authored papers 4
Joseph F Fraumeni
National Cancer Institute
Co-authored papers 4
Chand Khanna
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Release 1.2